SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-15-001437
Filing Date
2015-03-16
Accepted
2015-03-16 14:00:37
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031615.htm 10-K 1074174
2 EXHIBIT 23.1 exh_231.htm EX-23.1 8073
3 EXHIBIT 31.1 exh_311.htm EX-31.1 12391
4 EXHIBIT 31.2 exh_312.htm EX-31.2 12564
5 EXHIBIT 32.1 exh_321.htm EX-32.1 9862
  Complete submission text file 0001171843-15-001437.txt   4651671

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT caps-20141231.xml EX-101.INS 551717
7 XBRL TAXONOMY EXTENSION SCHEMA caps-20141231.xsd EX-101.SCH 33405
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20141231_cal.xml EX-101.CAL 32092
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20141231_def.xml EX-101.DEF 179276
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20141231_lab.xml EX-101.LAB 239376
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20141231_pre.xml EX-101.PRE 218592
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21214 | Film No.: 15702142
SIC: 2834 Pharmaceutical Preparations